No Data
Hunan Warrant Pharmaceutical Co.,Ltd's (SHSE:688799) Stock Price Dropped 10% Last Week; Private Companies Would Not Be Happy
Warner Pharmaceuticals: Third Quarter Report 2024
Third Quarter Report 2024
Warner Pharmaceutical Factory (688799.SH): net income in the first three quarters was 0.158 billion yuan, a year-on-year increase of 0.09%.
GloryMed reports on October 28th that Warner Pharm (688799.SH) released the third quarter report for 2024, with revenue of 1.069 billion yuan for the first three quarters, a year-on-year increase of 1.28%; net income attributable to shareholders of the listed company was 0.158 billion yuan, a year-on-year increase of 0.09%; and basic earnings per share were 1.69 yuan.
Warrant Pharmaceutical Gets Marketing License for Terbutaline Sulfate Nebulized Inhalation Solution; Shares Rise 4%
Warner Pharmaceuticals (688799.SH): The pharmaceutical supplementary application approval notice for the aerosol inhalation solution of terbutaline sulfate has been obtained.
On October 17, Gelonghui announced that Warner Pharmaceutical Factory (688799.SH) received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration regarding the change of the pharmaceutical license holder for the market approval of the pharmaceutical solution of terbutaline sulfate for inhalation. Terbutaline sulfate inhalation solution is suitable for relieving bronchial asthma, chronic bronchitis, emphysema, and bronchospasm associated with other pulmonary diseases.
Hunan Warrant Pharmaceutical Co.,Ltd's (SHSE:688799) Shares Bounce 43% But Its Business Still Trails The MarketNo Data
No Data
